Reyataz Related Clinical Trials
Atazanavir Twice Daily [Completed]
Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV [Active, not recruiting]
Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone [Completed]
Drug Interaction Study With Proton Pump Inhibitor [Completed]
Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects [Completed]
Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients [Completed]
Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients [Completed]
BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated. [Recruiting]
Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study [Active, not recruiting]
ATV/Ritonavir Nevirapine Interaction (USPAC) [Completed]
The Effects of Atazanavir-Induced Hyperbilirubinemia During Human Endotoxemia [Recruiting]
Atazanavir and Lamivudine for Treatment Simplification [Not yet recruiting]
Effects of Gastric pH on the Pharmacokinetics of Atazanavir [Recruiting]
Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir [Completed]
Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression [Recruiting]
Drug Interactions Between Atazanavir Plus Ritonavir Coadministered With Voriconazole in Healthy Subjects [Recruiting]
Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study) [Completed]
Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens [Recruiting]
SHARE: Simple HAART With Abacavir, Reyataz, and Epivir [Recruiting]
Two Clinical Trials to Evaluate Pharmacokinetics of Unboosted and Boosted Atazanavir Used Alone or Co-administered With Tenofovir DF in Healthy Korean and Caucasian Male Volunteers [Not yet recruiting]
Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females [Completed]
Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV Infected Infants, Children, and Adolescents [Active, not recruiting]
PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV) [Not yet recruiting]
Study of Reyataz in HIV-Infected Patients With Lipodystrophy Syndrome [Active, not recruiting]
Bioequivalence Study of Atazanavir 300 mg Capsule [Completed]
Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women [Recruiting]
Atazanavir/Ritonavir (ATV/RTV) Once a Day (QD) + Raltegravir (RAL) Twice a Day (BID) Stable Switch Study [Recruiting]
Switch to Unboosted Atazanavir With Tenofovir Study [Recruiting]
Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment [Recruiting]
Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population [Recruiting]
Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients [Terminated]
A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE) [Recruiting]
Study to Evaluate the Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in HIV-Infected Subjects Evidencing Virologic Suppression [Active, not recruiting]
Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression [Recruiting]
Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia [Completed]
The Effect of Atazanavir and Ritonavir on the Pharmacokinetics of Oral Norethindrone [Recruiting]
A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy [Completed]
Korean Post-marketing Surveillance for Reyataz® [Recruiting]
Study of Boosted Atazanavir (ATV) Versus Non-Boosted ATV in Naive Patients [Completed]
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2) [Recruiting]
Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients [Suspended]
Raltegravir and Atazanavir Dosing Strategy Study [Recruiting]
BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada [Active, not recruiting]
A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir [Not yet recruiting]
Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe [Recruiting]
Metabolic Effects of Switching Kaletra to Boosted Reyataz [Recruiting]
Atazanavir/Ritonavir and Zinc Pharmacokinetic Study [Not yet recruiting]
Phase IIB Pilot of Atazanavir + Raltegravir [Recruiting]
Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients [Recruiting]
Raltegravir vs. Atazanavir in Combination With Truvada� for the Treatment of Antiretroviral na�ve HIV Infected Patients [Recruiting]
Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression [Recruiting]
Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment [Active, not recruiting]
Boosted Atazanavir and Truvada Given Once-Daily - BATON Study [Completed]
Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir DF in HIV-1-Infected Treatment Naive Adults [Active, not recruiting]
Effect of Atazanavir on Endothelial Function in HIV-Infected Patients [Completed]
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection [Active, not recruiting]
Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada [Recruiting]
Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users [Recruiting]
Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment [Recruiting]
Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA) [Recruiting]
Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy [Recruiting]
DDI HV (ATV - Merck) [Completed]
Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-Infected Patients That Have Never Received Treatment. [Recruiting]
Drug Interaction Study [Active, not recruiting]
A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine [Completed]
A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor [Terminated]
A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients [Recruiting]
A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV [Completed]
Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction [Recruiting]
A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen [Completed]
BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes [Recruiting]
Pilot Study of a Raltegravir Based NRTI Sparing Regimen [Recruiting]
Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs [Completed]
A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome [Completed]
Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment [Completed]
"The Once A Day Protease Inhibitor Regimens" [Active, not recruiting]
Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients [Completed]
Atazanavir or Lopinavir in HIV Post-Exposure Prophylaxis [Not yet recruiting]
A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study [Active, not recruiting]
Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults [Recruiting]
Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults [Active, not recruiting]
Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women [Recruiting]
Atazanavir/Ritonavir Maintenance Therapy [Active, not recruiting]
Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV [Recruiting]
Atazanavir for HIV Infected Individuals: An Early Access Program
Standard Antiretroviral v. Multi-Class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01) [Recruiting]
Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy [Recruiting]
Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r [Recruiting]
Evaluation of Atazanavir Substitution Intervention (EASI) Study [Recruiting]
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults [Active, not recruiting]
Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients [Completed]
Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir [No longer recruiting]
Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy Women [Recruiting]
Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in HIV Infected Naive Patients (NEwArT) [Recruiting]
Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s) [Completed]
Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients [No longer recruiting]
Preventing Sexual Transmission of HIV With Anti-HIV Drugs [Recruiting]
Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study [Recruiting]
Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects [Completed]
A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-Based HAART Regimens in HIV-Infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-Containing HAART Regimen [Completed]
Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults [Recruiting]
|
